Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Dr. Falk Pharma GmbH
Sponsor

Dr. Falk Pharma GmbH

Germany Leinenweberstrasse 5, Hochdorf, 79108 Freiburg Im Breisgau, Germany

About the sponsor

Dr. Falk Pharma GmbH is active in eosinophilic esophagitis and in the prevention of oesophageal strictures after endoscopic treatment, with a clear focus on conditions affecting the oesophagus and swallowing function.

  • Eosinophilic esophagitis
  • Oesophageal stricture prevention
  • Budesonide orodispersible tablets

The sponsor also funds work on acute radiation proctitis, extending its interest in gastrointestinal inflammation beyond the upper digestive tract.

About Specializations

Dr. Falk Pharma GmbH runs clinical trials in conditions such as Cholangitis sclerosing, Coeliac disease, Proctitis, Eosinophilic oesophagitis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

7 clinical trials

Coeliac disease

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH

Proctitis

Recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Dr. Falk Pharma GmbH

Eosinophilic oesophagitis

Recruiting
Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Dr. Falk Pharma GmbH

Cholangitis sclerosing

Not recruiting
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Norucholic Acid
  • Sponsor:Dr. Falk Pharma GmbH

Impaired gastric emptying+1

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Naronapride Dihydrochloride Trihydrate
  • Sponsor:Dr. Falk Pharma GmbH

Oesophageal squamous cell carcinoma+2

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Dr. Falk Pharma GmbH

Cholangitis sclerosing

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Norucholic Acid
  • Sponsor:Dr. Falk Pharma GmbH

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.